Ellen Lund Sagen

711 total citations
23 papers, 541 citations indexed

About

Ellen Lund Sagen is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Ellen Lund Sagen has authored 23 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Molecular Biology and 5 papers in Surgery. Recurrent topics in Ellen Lund Sagen's work include Atherosclerosis and Cardiovascular Diseases (11 papers), Inflammasome and immune disorders (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Ellen Lund Sagen is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (11 papers), Inflammasome and immune disorders (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Ellen Lund Sagen collaborates with scholars based in Norway, Netherlands and Denmark. Ellen Lund Sagen's co-authors include Bente Halvorsen, Pål Aukrust, Mona Skjelland, Kirsten Krohg‐Sørensen, Sverre Holm, Arne Yndestad, Annika E. Michelsen, Thor Ueland, Tuva B. Dahl and David Russell and has published in prestigious journals such as PLoS ONE, Stroke and Scientific Reports.

In The Last Decade

Ellen Lund Sagen

21 papers receiving 533 citations

Peers

Countries citing papers authored by Ellen Lund Sagen

Since Specialization

Citations

This map shows the geographic impact of Ellen Lund Sagen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Lund Sagen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Lund Sagen more than expected).

Fields of papers citing papers by Ellen Lund Sagen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Lund Sagen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Lund Sagen. The network helps show where Ellen Lund Sagen may publish in the future.

Co-authorship network of co-authors of Ellen Lund Sagen

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Lund Sagen. A scholar is included among the top collaborators of Ellen Lund Sagen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Lund Sagen. Ellen Lund Sagen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	T cells enhance development of atherosclerosis in LDL Receptor knock out mice 2025 ·Atherosclerosis ·(unknown), Xiang Yi Kong, Sverre Holm, Ellen Lund Sagen, Tuva B. Dahl, Bente Halvorsen	0
2	Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of anabolic-androgenic steroids 2024 ·European Journal of Preventive Cardiology ·(unknown), (unknown), (unknown), Per Medbøe Thorsby, Lisa E. Hauger, Kristina H. Haugaa, Ellen Lund Sagen, Annika E. Michelsen, Thor Ueland, Thor Edvardsen, Pål Aukrust, Vibeke Marie Almaas, Astrid Bjørnebekk, Bente Halvorsen	3
3	High viral loads combined with inflammatory markers predict disease severity in hospitalized COVID‐19 patients: Results from the NOR‐Solidarity trial 2024 ·Journal of Internal Medicine ·(unknown), (unknown), Ellen Lund Sagen, Annika E. Michelsen, (unknown), Trine Kåsine, Kateřina Nezvalová‐Henriksen, Anne Ma Dyrhol‐Riise, Tøri Vigeland Lerum, Fredrik Müller, Kristian Tonby, Anders Tveita, Pål Aukrust, Marius Trøseid, Thor Ueland, Tuva B. Dahl	0
4	Extracellular matrix remodelling pathway in peripheral blood mononuclear cells from severe COVID-19 patients: an explorative study 2024 ·Frontiers in Immunology ·Sarah Louise Murphy, (unknown), Trine Ranheim, Ellen Lund Sagen, (unknown), Vigdis Bjerkeli, Annika E. Michelsen, (unknown), Lars Heggelund, Anne Ma Dyrhol‐Riise, Anders Tveita, Aleksander Rygh Holten, Marius Trøseid, Thor Ueland, Thomas Ulas, Pål Aukrust, Andreas Barratt‐Due, Bente Halvorsen, Tuva B. Dahl	1
5	Alveolar hypoxia induces organ‐specific inflammasome‐related inflammation in male mouse lungs 2024 ·Physiological Reports ·(unknown), (unknown), Xiang Yi Kong, Ellen Lund Sagen, (unknown), Kuan Yang, Else Marit Løberg, Geir Christensen, Ole Henning Skjønsberg, Karl‐Otto Larsen	1
6	NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype 2021 ·Scientific Reports ·(unknown), Xiang Yi Kong, Sverre Holm, (unknown), Tuva B. Dahl, Kuan Yang, Ellen Lund Sagen, (unknown), Jonas Øgaard, Kristian Holm, Beate Vestad, Maria Belland Olsen, Pål Aukrust, Magnar Bjørås, Johannes R. Hov, Bente Halvorsen, Ida Gregersen	4
7	Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria 2020 ·BMC Infectious Diseases ·Kari Otterdal, Åse Berg, Annika E. Michelsen, Sam Patel, Ida Gregersen, Ellen Lund Sagen, Bente Halvorsen, Arne Yndestad, Thor Ueland, Nina Langeland, Pål Aukrust	10
8	Neuromodulatory Effect of NLRP3 and ASC in Neonatal Hypoxic Ischemic Encephalopathy 2019 ·Neonatology ·(unknown), Katja Scheffler, Rajikala Suganthan, Magnar Bjørås, Trine Ranheim, Ellen Lund Sagen, Bente Halvorsen, Ola Didrik Saugstad, Arne Yndestad	27
9	Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction 2019 ·EBioMedicine ·(unknown), Romain A. Colas, Anne Kristine Anstensrud, Ida Gregersen, Ståle H. Nymo, Ellen Lund Sagen, Annika E. Michelsen, Leif Erik Vinge, Erik Øie, Lars Gullestad, Bente Halvorsen, Trond Vidar Hansen, Pål Aukrust, Jesmond Dalli, Arne Yndestad	30
10	Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals 2019 ·The Journal of Infectious Diseases ·Hedda Hoel, Thor Ueland, Andreas Dehlbæk Knudsen, Andreas Kjær, Annika E. Michelsen, Ellen Lund Sagen, Bente Halvorsen, Arne Yndestad, Susanne Dam Nielsen, Pål Aukrust, Anne‐Mette Lebech, Marius Trøseid	17
11	Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack 2018 ·Journal of the American Heart Association ·(unknown), Mona Skjelland, Xiang Yi Kong, Karolina Skagen, Sverre Holm, Kari Otterdal, Christen P. Dahl, Kirsten Krohg‐Sørensen, Ellen Lund Sagen, Vigdis Bjerkeli, Anne Hege Aamodt, Azhar Abbas, Ida Gregersen, Pål Aukrust, Bente Halvorsen, Tuva B. Dahl	50
12	Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages 2017 ·Biochemical and Biophysical Research Communications ·Sandra Espada, Benedicte Stavik, Sverre Holm, Ellen Lund Sagen, Vigdis Bjerkeli, Mona Skjelland, Tuva B. Dahl, Terje Espevik, Sandip M. Kanse, Per Morten Sandset, Grethe Skretting, Bente Halvorsen	11
13	Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation 2017 ·PLoS ONE ·Ida Gregersen, Øystein Sandanger, Erik T. Askevold, Ellen Lund Sagen, Kuan Yang, Sverre Holm, Turid M. Pedersen, Mona Skjelland, Kirsten Krohg‐Sørensen, Trond Vidar Hansen, Tuva B. Dahl, Kari Otterdal, Terje Espevik, Pål Aukrust, Arne Yndestad, Bente Halvorsen	23
14	Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages 2015 ·Atherosclerosis ·Bente Halvorsen, (unknown), Geir Øystein Andersen, Arne Yndestad, Ellen Lund Sagen, Azita Rashidi, Eva Cecilie Knudsen, Mona Skjelland, Karolina Skagen, Kirsten Krohg‐Sørensen, Sverre Holm, (unknown), Kirsten B. Holven, Erik A.L. Biessen, Pål Aukrust, Tuva B. Dahl	50
15	Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis 2014 ·PLoS ONE ·Azhar Abbas, Pål Aukrust, David Russell, Kirsten Krohg‐Sørensen, (unknown), (unknown), Vigdis Bjerkeli, Ellen Lund Sagen, Annika E. Michelsen, Tuva B. Dahl, Sverre Holm, Thor Ueland, Mona Skjelland, Bente Halvorsen	69
16	Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13 2014 ·Atherosclerosis ·Bente Halvorsen, (unknown), Annika E. Michelsen, Mona Skjelland, Vigdis Bjerkeli, Ellen Lund Sagen, Kjetil Taskén, Bjørn Bendz, Lars Gullestad, Sverre Holm, Erik A.L. Biessen, Pål Aukrust	26
17	Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis – Potential role in plaque stabilization 2012 ·Atherosclerosis ·(unknown), Bente Halvorsen, Isabelle Daissormont, Trine Ranheim, Annika E. Michelsen, Mona Skjelland, Ellen Lund Sagen, Lasse Folkersen, Kirsten Krohg‐Sørensen, David Russell, Sverre Holm, Thor Ueland, Børre Fevang, Ulf Hedin, Arne Yndestad, Lars Gullestad, Göran K. Hansson, Erik A.L. Biessen, Pål Aukrust	30
18	Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor 2006 ·Journal of Molecular and Cellular Cardiology ·Geir Florholmen, Bente Halvorsen, Kahsai Beraki, Torstein Lyberg, Ellen Lund Sagen, Pål Aukrust, Geir Christensen, Arne Yndestad	13
19	8‐isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP‐1 macrophages, resulting in long‐lived foam cells 2004 ·European Journal of Clinical Investigation ·Hanne Scholz, Pål Aukrust, Jan Kristian Damås, Serena Tonstad, Ellen Lund Sagen, Svein O. Kolset, Christian Hall, Arne Yndestad, Bente Halvorsen	28
20	Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma 2001 ·Scandinavian Journal of Clinical and Laboratory Investigation ·(unknown), (unknown), Ellen Lund Sagen, Julie Smith, (unknown), Christian Hall	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact